Price Controls
CCAGW Year in Review in the States
In 2022, CCAGW helped protect taxpayers with wins on data privacy, broadband spending, drug price controls, and reducing red tape.
The Inflation Reduction Act Will Raise Drug Costs and Reduce Cures
Price controls in the Inflation Reduction Act will devastate future drug development and raise costs.
The Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
Price Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
Price Controls Will Create an Invisible Graveyard of Americans
The Build Back Better Act will cost lives by devastating the development of future cures.
Build Back Better Act: Not Dead Yet
The $1.75 trillion Build Back Better Act has had a tough week and is on life support.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Price Controls Must Not Be Included in Reconciliation
The Biden administration and congressional leaders aim to implement price controls on healthcare.
What’s Worse than Most Favored Nation – Budget Reconciliation
The Biden administration proposes to recind President Trump's Most Favored Nation Policy.
No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill
Sen. Ron Wyden (D-Ore.) wants to use price controls in Medicare Part D to pay for President Biden's extravagant spending.
No Surprises Act Gets its First Interim Rule
The No Surprises Act was passed last year to stop surprise medical bills but in reality the law will end up causing more problems.
